In a recently issued opinion, the Fifth Circuit has added yet another chapter to the growing debate over whether providers may seek judicial enforcement of Independent Dispute Resolution (“IDR”) awards issued under the No Surprises Act (“NSA”).  In a much-anticipated decision, the Fifth Circuit has held that the NSA does not permit providers to bring private actions to enforce IDR awards, siding squarely with payers on this increasingly litigated question.  The ruling sharpens a growing divide, leaving providers and payers to navigate an unsettled and increasingly complex enforcement landscape. 

The Court’s Ruling: A Comprehensive Rejection of Private Enforcement Mechanisms

The underlying litigation arose after two air ambulance providers—Guardian Flight, LLC and Med-Trans Corporation—secured favorable IDR awards against Health Care Service Corporation (“HCSC”) under the NSA, which establishes a binding arbitration process for resolving payment disputes between out-of-network providers and insurers.  After receiving either delayed payment or no payment on numerous awards, the providers filed suit in the District Court for the Northern District of Texas to enforce the awards.  After the District Court dismissed the case, reasoning that the NSA does not include an express provision allowing for the enforcement of arbitration awards under the FAA, the providers appealed.  On appeal, the providers alleged multiple causes of action, including (1) that HCSC’s failure to timely pay the awards violated the NSA itself; (2) that HCSC’s refusal to pay the awards constituted a denial of benefits under ERISA as assignees of plan beneficiaries; and (3) that HCSC had been unjustly enriched under state law by retaining the benefit of services provided without compensation. 

The Fifth Circuit rejected each claim in turn.

First, on the core NSA claim, the court held that the statute contains no private right of action permitting judicial enforcement of IDR awards.  Noting that the NSA expressly limits judicial review of IDR awards to narrow circumstances—fraud, corruption, or certain procedural errors— borrowed from the Federal Arbitration Act (“FAA”), the court reasoned that the statutory text of the NSA reflected a deliberate policy choice by Congress to channel enforcement through the administrative complaint process overseen by the U.S. Department of Health and Human Services (“HHS”).  The court concluded that any form of court-ordered enforcement necessarily constitutes judicial review and was therefore barred absent an applicable FAA exception.  This holding conflicts directly with other district court rulings—including a recent Connecticut decision—that have found implied enforcement rights under either the NSA or the FAA. 

Second, the court affirmed the dismissal of the providers’ ERISA claims for lack of Article III standing.  While the providers had obtained valid assignments of benefits from their patients, the court held that the patients themselves had suffered no concrete injury as the NSA shields them from financial responsibility for out-of-network costs.  Without actual harm to the beneficiaries, the Fifth Circuit declared, the providers—standing in the shoes of their assignors—lacked standing to assert derivative ERISA claims for unpaid plan benefits.  This is an argument that health plans may attempt to recycle in other contexts. 

Finally, the court also affirmed the dismissal of the providers’ state law-based quantum meruit claims.  Here, the court emphasized that under Texas precedent, health care services provided for the benefit of a patient cannot support a claim for unjust enrichment against an insurer, as the services at issue were not rendered for the insurer’s benefit.  The court declined the providers’ invitation to carve out an exception for NSA-related services, concluding that established Texas law foreclosed their theory. 

What’s Next?  Growing Entrenchment of Conflicting Approaches

The Fifth Circuit’s decision marks a clear and categorical endorsement of the “no private right of action” camp, deepening the divide between courts that have found implied enforcement authority under the NSA and those that have rejected it.  With district courts in Connecticut, New Jersey, and Texas having previously staked out competing positions—and now with a federal appellate decision adding further weight on one side—the issue continues to mature toward ongoing appellate (and potentially Supreme Court) resolution.  In the interim, the Fifth Circuit’s ruling is likely to embolden payers in ongoing disputes, while providers operating in different jurisdictions will face a patchwork of inconsistent judicial interpretations depending on where payment disputes begin.  Meanwhile, although HHS retains authority to compel compliance through administrative enforcement mechanisms, this decision underscores that providers remain at the mercy of federal regulators in jurisdictions that reject private enforcement remedies under the NSA. 

Proskauer’s Health Care Group is actively monitoring developments related to the No Surprises Act and its implementation.  For more insights into this and related regulatory trends, subscribe to our Health Care Law Brief

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Vinay Kohli Vinay Kohli

Vinay Kohli is a healthcare industry lawyer.  Recognized for his focus and commitment to the healthcare industry, a wide range of healthcare businesses use Vinay as an outside general counsel to guide them on strategic planning, compliance matters, operational questions, and reimbursement concerns. …

Vinay Kohli is a healthcare industry lawyer.  Recognized for his focus and commitment to the healthcare industry, a wide range of healthcare businesses use Vinay as an outside general counsel to guide them on strategic planning, compliance matters, operational questions, and reimbursement concerns.  He provides regulatory, compliance, and reimbursement advice on topics that range from venture formation, technology implementation, and risk management to day-to-day contract negotiations.

Vinay’s background is unique in that he is also a seasoned trial lawyer.  He is able to combine his regulatory expertise with a trial lawyer skillset for jury trials, bench trials, and arbitrations arising in the healthcare arena—he represents hospital systems, physician practices, providers of post-acute care services, as well as healthcare technology and revenue cycle management companies. He defends health care fraud and abuse litigation, prosecutes managed care disputes against large national payors, and handles government investigations.  And clients frequently call upon Vinay to serve as lead trial counsel in commercial litigation disputes that span the gamut from breach of contract and trade secret misappropriation to unfair business practices and breach of fiduciary claims.

Vinay received his B.B.A., magna cum laude, M.A., and J.D. from the University of Texas at Austin in 2005, 2006, and 2009 respectively.

Prior to joining Proskauer, Vinay was a partner in the Healthcare group at King & Spalding.

Photo of Matthew J. Westbrook Matthew J. Westbrook

Matt Westbrook is an associate in the Corporate Department and a member of the Health Care Group. His practice focuses on providing regulatory compliance advice for the Firm’s health care clients, including service providers, health plans, operators, investors, and lenders, among others. Matt…

Matt Westbrook is an associate in the Corporate Department and a member of the Health Care Group. His practice focuses on providing regulatory compliance advice for the Firm’s health care clients, including service providers, health plans, operators, investors, and lenders, among others. Matt specifically provides advice on fraud and abuse matters arising under the Federal False Claims Act (FCA), Civil Monetary Penalties Law, Federal Anti-Kickback Statute (AKS), and Physician Self-Referral Law (Stark Law), as well as on the regulations promulgated by the Drug Enforcement Administration (DEA) and the Department of Health and Human Services, including the Office of Inspector General (OIG), Centers for Medicare & Medicaid Services (CMS), and Food and Drug Administration (FDA).

Before joining the Firm, Matt served as senior counsel in OIG’s Administrative and Civil Remedies Branch. At OIG, Matt was responsible for determining whether to impose administrative sanctions, including civil money penalties and Federal health care program exclusions, against health care providers and suppliers, and whether to impose civil money penalties on hospitals and physicians in connection with matters referred to CMS under the Emergency Medical Treatment and Labor Act (EMTALA). During his tenure, Matt also litigated exclusion appeals before administrative law judges and appellate panels of the Departmental Appeals Board; advised United States Attorney’s Offices on exclusions appealed to Federal district courts; resolved voluntary self-disclosures submitted by providers and grant and contract recipients; and participated in the negotiations and settlements of FCA matters by the Department of Justice involving the AKS, Stark Law, CMS reimbursement issues, and DEA and FDA compliance issues. In connection with certain FCA resolutions, Matt also negotiated and monitored corporate integrity agreements.

On the Florida junior circuit and in college, Matt was a competitive tennis player. Matt played on the varsity team and was captain his senior year at Rhodes College, earning ITA Division III and SCAC All-Academic Honor Roll awards his sophomore, junior, and senior years. Matt is an active member of the American Health Law Association (AHLA) and currently serves as a Vice Chair of AHLA’s Fraud and Abuse Practice Group.

Photo of D. Austin Rettew D. Austin Rettew

Austin Rettew is an associate in the Corporate and Litigation Departments and a member of the Health Care Group at Proskauer.  His practice focuses on regulatory litigation and compliance within the health care sector.  He provides strategic counsel to health care providers on…

Austin Rettew is an associate in the Corporate and Litigation Departments and a member of the Health Care Group at Proskauer.  His practice focuses on regulatory litigation and compliance within the health care sector.  He provides strategic counsel to health care providers on managed care and commercial payer disputes, offering comprehensive regulatory, compliance, and reimbursement guidance to a diverse client base, including hospital systems, dialysis providers, anesthesia associations, physician practices, post-acute care service providers, and healthcare technology and revenue cycle management companies.

Austin is experienced in regulatory litigation and routinely advises clients operating within the complex landscape of the heavily regulated health care industry.  His work in this area addresses compliance issues related to ERISA, the Affordable Care Act, the Medicare Secondary Payer Act, the Medicare Advantage program, the federal No Surprises Act, state surprise billing laws, state insurance laws, and the Mental Health Parity and Addiction Equity Act.  He has represented providers, pharmaceutical manufacturers, and other health care companies in government investigations involving the Anti-Kickback Statute, the False Claims Act, and qui tam “whistleblower” lawsuits, working closely with company executives and consultants to develop effective compliance regimes while minimizing business disruption.

Austin also advises investors, owners, operators, and developers of long-term care and senior housing communities on health care transactions, regulatory compliance, corporate due diligence, and change of ownership procedures for state licensure, certificate of need, and Medicare and Medicaid certifications.  He also drafts industry-specific comment letters for proposed regulations, ensuring that client perspectives and concerns are clearly communicated to regulatory bodies.

While in law school, Austin was an articles editor of the George Washington University Law School’s Public Contract Law Journal.  Austin also served as a judicial intern for Judge Elizabeth S. Stong of the U.S. Bankruptcy Court for the Eastern District of New York and Magistrate Judge Lois Bloom of the U.S. District Court for the Eastern District of New York.

Prior to joining Proskauer, Austin was an associate in the Complex Litigation group at ArentFox Schiff.